BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16004172)

  • 1. Mycobacterium avium complex pulmonary disease in immunocompetent patients.
    Chitty SA; Ali J
    South Med J; 2005 Jun; 98(6):646-52. PubMed ID: 16004172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung).
    Khoor A; Leslie KO; Tazelaar HD; Helmers RA; Colby TV
    Am J Clin Pathol; 2001 May; 115(5):755-62. PubMed ID: 11345841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nontubercular mycobacterial pulmonary infection in immunocompetent men.
    Kanathur N; Shantaveerapa HN; Byrd RP; Mehta JB; Roy TM
    South Med J; 2001 Jul; 94(7):719-23. PubMed ID: 11531180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of nontuberculous mycobacterial disease.
    Griffith DE
    Curr Opin Infect Dis; 2007 Apr; 20(2):198-203. PubMed ID: 17496580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of infections due to Mycobacterium avium complex.
    Kasperbauer SH; Daley CL
    Semin Respir Crit Care Med; 2008 Oct; 29(5):569-76. PubMed ID: 18810690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Mycobacterium avium complex pulmonary disease in an immunocompetent host.
    Khan ZU; Guardiola J; Salzman G
    South Med J; 2005 Oct; 98(10):1036-8. PubMed ID: 16295821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When and how to treat pulmonary non-tuberculous mycobacterial diseases.
    Thomson RM; Yew WW
    Respirology; 2009 Jan; 14(1):12-26. PubMed ID: 19144045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection with the Mycobacterium avium complex in patients without predisposing conditions: a case report and literature review.
    Martins AB; Matos ED; Lemos AC
    Braz J Infect Dis; 2005 Apr; 9(2):173-9. PubMed ID: 16127595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of the lung diseases due to Mycobacterium avium and Mycobacterium intracellulare classified by DNA probe test].
    Urano T; Nozaki H; Matsumoto S; Nagatomi H; Kakazu Y; Watabiki S; Hiroki F; Yoshitake S; Aoyagi T; Asami O
    Kekkaku; 1990 Oct; 65(10):639-41. PubMed ID: 2259056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overview of respiratory infection caused by nontuberculous mycobacteria].
    Fujita J; Hibiya K; Haranaga S; Higa F; Tateyama M
    Kekkaku; 2007 Sep; 82(9):721-7. PubMed ID: 17969990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
    Kuwabara K; Tsuchiya T
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary Mycobacterium avium infections in non-immunosuppressed patients: a new disease?].
    Konietzko N
    Pneumologie; 2000 Oct; 54(10):454-7. PubMed ID: 11089398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
    Davis KK; Kao PN; Jacobs SS; Ruoss SJ
    BMC Pulm Med; 2007 Feb; 7():2. PubMed ID: 17319962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease.
    Frothingham R
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1990-1. PubMed ID: 8665069
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of glycopeptidolipid core antigen for serodiagnosis of mycobacterium avium complex pulmonary disease in immunocompetent patients.
    Kitada S; Maekura R; Toyoshima N; Naka T; Fujiwara N; Kobayashi M; Yano I; Ito M; Kobayashi K
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):44-51. PubMed ID: 15642983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.
    Moon SM; Jhun BW; Lee H; Park HY; Jeon K; Lee SY; Koh WJ
    J Infect Chemother; 2017 Sep; 23(9):658-660. PubMed ID: 28284662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypersensitivity pneumonitis and abscess reaction to nontuberculous mycobacteria acquired form jacuzzi aerosol].
    Balavoine C; Lanotte P; Campana M; Ghanem M; Marchand-Adam S
    Rev Mal Respir; 2019 Jan; 36(1):57-62. PubMed ID: 30573310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.